论文部分内容阅读
通过对照性临床研究观察国产环孢素A对难治性肾病的疗效。48例难治性肾病患者随机分为治疗对照组和观察组,治疗对照组给予类固醇激素常规治疗,观察组给予环孢素A、肝素联合疗法。经治疗6个月后,观察组总有效率达75%,完全缓解10例,占42%,部分缓解8例,占33%,无效6例,占25%。对照组完全缓解5例,占21%,部分缓解6例,占25%,两组的完全缓解率与部分缓解率差异显著(P<0.05)。环孢素A、肝素联合疗法对难治性肾病疗效肯定,值得推广。
To observe the curative effect of domestic cyclosporin A on refractory nephropathy by comparative clinical study. Forty-eight patients with refractory nephropathy were randomly divided into treatment control group and observation group. The control group was given routine steroid treatment. The observation group was given cyclosporin A and heparin combined therapy. After 6 months of treatment, the total effective rate of the observation group was 75%, complete remission in 10 cases, 42%, partial remission in 8 cases, 33%, 6 cases ineffective, accounting for 25%. The control group completely relieved in 5 cases, accounting for 21%, partially relieved in 6 cases, accounting for 25%. The complete remission rate and partial remission rate were significantly different between the two groups (P <0.05). Cyclosporin A, heparin combined therapy for the treatment of refractory renal disease affirmed, it is worth promoting.